Request Demo
Last update 20 Jul 2025
SCTB-35
Last update 20 Jul 2025
Overview
Basic Info
Drug Type Bispecific T-cell Engager (BiTE) |
Synonyms SCTB35 |
Target |
Action inhibitors, stimulants |
Mechanism CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), CD3 stimulants(T cell surface glycoprotein CD3 stimulants) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with SCTB-35NCT06841042
A Phase Ib/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SCTB35 in Patients with Systemic Lupus Erythematosus
CTR20244176
一项评估SCTB35在系统性红斑狼疮受试者中的安全性、耐受性、药代动力学、有效性的Ib/II期临床研究
[Translation] A Phase Ib/II clinical study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of SCTB35 in subjects with systemic lupus erythematosus
NCT06318884
A Phase Ia/Ib Dose-escalation and Dose-expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SCTB35 in Patients With CD20+ Relapse/Refractory B-cell Non-Hodgkin Lymphoma
100 Clinical Results associated with SCTB-35
Login to view more data
100 Translational Medicine associated with SCTB-35
Login to view more data
100 Patents (Medical) associated with SCTB-35
Login to view more data
100 Deals associated with SCTB-35
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Systemic Lupus Erythematosus | Phase 2 | China | 01 Feb 2025 | |
| CD20 Positive B-Cell Non-Hodgkin Lymphoma | Phase 1 | China | 09 Apr 2024 | |
| CD20 positive B-Cell Lymphoma | Phase 1 | China | 01 Apr 2024 | |
| Autoimmune Diseases | IND Approval | China | 11 Sep 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free